ArticleWorld journal of gastroenterology2002
Analysis for phenotype of HNPCC in China.
Article in World journal of gastroenterology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 12 citations in OpenAlex.
- Extracolonic manifestations of lynch syndrome.Clinics in colon and rectal surgery · 2012Article
- Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.World journal of gastroenterology · 2006Article
- Hereditary Non-Polyposis Colorectal Cancer: the rise and fall of a confusing term.World journal of gastroenterology · 2006Review
- Hereditary colorectal cancer in china.Hereditary cancer in clinical practice · 2005Article
- Genetic detection of Chinese hereditary nonpolyposis colorectal cancer.World journal of gastroenterology · 2004Article
- Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.World journal of gastroenterology · 2003Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThe aims of this study were to identify the clinicopathological features of Chinese HNPCC families and to evaluate the value of criteria for suspected HNPCC (sHNPCC) in clinical diagnosis.
methodsAccording to the follow-up records, 54 HNPCC families (including 12 ICG-HNPCC families and 42 sHNPCC families) were screened out from patients with colorectal cancers (CRCs), operated upon in 2(nd) Affiliated Hospital of Zhejiang University from 1984 to 2001. Clinical data of probands and tumor spectrum in these families were listed and analyzed.
results(1) Mean age, proportion of colonic cancer, poorly differentiated cancer, multiple CRCs and Dukes' A+B of the probands in ICG-HNPCC and sHNPCC kindred were 39ys and 47.5ys, 75 % and 62 %, 0 and 12.8 %, 16.7 % and 14.3 %, 58.3 % and 81 %,respectively. Compared with sporadic colorectal cancers, probands from ICG-HNPCC and sHNPCC families were obviously different at age of onset (P=0.025 and 0.031), tumor location (P=0.001 and 0.000), differentiation(P=0.002 and 0.011) and development of multiple tumors (P=0.014 and 0.002). (2) A total of 178 malignant neoplasms were found in 54 HNPCC families, including 139 colorectal cancers. Besides of colorectal cancer, extracolonic tumors occurred in stomach, endometrium, hepatobiliary system, and so on (8 gastric cancers, 6 endometrial cancers, 6 hepatobiliary system cancers and 19 others) can also be seen in Chinese ICG-HNPCC and sHNPCC families.
conclusion(1) Chinese HNPCC families have specific clinicopathological features, such as early onset, predilection for the involvement of colon, tendency of multiple CRCs, development of extracolonic tumors and well differentiation. (2) The criteria for suspected HNPCC is useful in clinical diagnosis and management of HNPCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.